Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention: coronary artery calcium and polypill therapy.

Literature DB >> 24275688

Prevention: coronary artery calcium and polypill therapy.

Ruth Webster¹, Anthony Rodgers¹.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 24275688 DOI： 10.1038/nrcardio.2013.185

Source DB: PubMed Journal: Nat Rev Cardiol ISSN： 1759-5002 Impact factor: 32.419

× No keyword cloud information.

10 in total

Review 1. Risk factor thresholds: their existence under scrutiny.

Authors: M R Law; N J Wald
Journal: BMJ Date: 2002-06-29

Review 2. The cardiovascular polypill in high-risk patients.

Authors: Melvin Lafeber; Wilko Spiering; Kavita Singh; Rama K Guggilla; Vinodvenkatesh Patil; Ruth Webster
Journal: Eur J Prev Cardiol Date: 2011-10-21 Impact factor: 7.804

3. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).

Authors: Shanthi Mendis; Dele Abegunde; Salim Yusuf; Shah Ebrahim; Gerry Shaper; Hassen Ghannem; Bakuti Shengelia
Journal: Bull World Health Organ Date: 2005-11-10 Impact factor: 9.408

4. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events.

Authors: Jamal S Rana; Heidi Gransar; Nathan D Wong; Leslee Shaw; Michael Pencina; Khurram Nasir; Alan Rozanski; Sean W Hayes; Louise E Thomson; John D Friedman; James K Min; Daniel S Berman
Journal: Am J Cardiol Date: 2012-03-16 Impact factor: 2.778

5. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial.

Authors: Alan Rozanski; Heidi Gransar; Leslee J Shaw; Johanna Kim; Lisa Miranda-Peats; Nathan D Wong; Jamal S Rana; Raza Orakzai; Sean W Hayes; John D Friedman; Louise E J Thomson; Donna Polk; James Min; Matthew J Budoff; Daniel S Berman
Journal: J Am Coll Cardiol Date: 2011-04-12 Impact factor: 24.094

6. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Authors: Joseph Yeboah; Robyn L McClelland; Tamar S Polonsky; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; Jeffery J Carr; David C Goff; Philip Greenland; David M Herrington
Journal: JAMA Date: 2012-08-22 Impact factor: 56.272

7. A strategy to reduce cardiovascular disease by more than 80%.

Authors: N J Wald; M R Law
Journal: BMJ Date: 2003-06-28

8. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors: Márcio Sommer Bittencourt; Michael J Blaha; Ron Blankstein; Matthew Budoff; Jose D Vargas; Roger S Blumenthal; Arthur S Agatston; Khurram Nasir
Journal: J Am Coll Cardiol Date: 2013-10-23 Impact factor: 24.094

9. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Authors: Simon Thom; Neil Poulter; Jane Field; Anushka Patel; Dorairaj Prabhakaran; Alice Stanton; Diederick E Grobbee; Michiel L Bots; K Srinath Reddy; Raghu Cidambi; Severine Bompoint; Laurent Billot; Anthony Rodgers
Journal: JAMA Date: 2013-09-04 Impact factor: 56.272

Review 10. The answer is 17 years, what is the question: understanding time lags in translational research.

Authors: Zoë Slote Morris; Steven Wooding; Jonathan Grant
Journal: J R Soc Med Date: 2011-12 Impact factor: 5.344